Gemini Therapeutics

Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.

Gemini Therapeutics logo

Client Opportunity

Gemini Therapeutics is a biotechnology company pioneering precision therapeutics for patients with high-risk genetic profiles linked to dry age-related macular degeneration (AMD) and rare systemic diseases.

They partnered with The Bowdoin Group to help with their Vice President, Clinical Operations hire. This client’s goal was to engage with a candidate with experience with clinical trial study design, recruitment of patients for clinical trials, and cross-functional leadership skills. 

  • Demonstrates at least 15 years of clinical operations experience managing trials across a range of disease areas
  • Deep understanding of clinical trial study design
  • Proven track record recruiting patients for global/multi-site clinical trials across Phase 1 to Phase 3
  • A big picture and strategic thinker, able to formulate a vision of the future state of the company
The perfect candidate:
  • Demonstrates at least 15 years of clinical operations experience managing trials across a range of disease areas
  • Deep understanding of clinical trial study design
  • Proven track record recruiting patients for global/multi-site clinical trials across Phase 1 to Phase 3
  • A big picture and strategic thinker, able to formulate a vision of the future state of the company

TBG Process

  • Built out lists of cardiology focused companies 
  • Leverage The Bowdoin Group’s network within the life sciences 
  • Network with leaders in the space

  • Services:
    • Executive Search
  • Placements:
    • VP of Clinical Operations
  • Employee Count:
    • 10-49
  • Funding Rounds:
    • Post-IPO Equity
    • Publicly Traded
Client Result

As a result, the team welcomed their new Vice President, Clinical Operations, in June 2021.